Enveric Biosciences, Inc.
(NASDAQ : AMRH)

( )
AMRH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.44%30.2414.1%$177.94m
HZNPHorizon Therapeutics Plc -0.19%91.455.5%$174.64m
GWPHGW Pharmaceuticals Plc 0.17%218.366.1%$132.57m
CTLTCatalent, Inc. 0.86%109.982.1%$128.58m
BHCBausch Health Cos., Inc. 1.44%30.240.0%$123.31m
ICLRICON plc -0.81%196.434.2%$121.81m
UTHRUnited Therapeutics Corp. 1.75%202.7814.1%$98.97m
JAZZJazz Pharmaceuticals Plc 1.87%166.372.3%$88.00m
SAVACassava Sciences, Inc. -1.00%35.670.0%$69.79m
ARGXargenx SE 1.41%272.780.0%$50.95m
SAGESAGE Therapeutics, Inc. 5.19%75.677.6%$37.98m
PRGOPerrigo Co. Plc 0.65%40.416.9%$37.14m
AMRNAmarin Corp. Plc 0.59%5.111.5%$28.81m
PCRXPacira Biosciences, Inc. 1.71%69.439.9%$26.96m
ICPTIntercept Pharmaceuticals, Inc. 1.13%21.4116.8%$21.61m

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.